Integrating utilization-focused evaluation with business process modeling for clinical research improvement

Research Evaluation

Volumn 19, Issue 4, 2010, Pages 239-250

  Kagan, Jonathan M ^a   Rosas, Scott ^b   Trochim, William M K ^c  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Department of Research   (United States)

^c Cornell University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78649756660     PISSN: 09582029     EISSN: None     Source Type: Journal    
DOI: 10.3152/095820210X12827366906607     Document Type: Article

References (33)

1. Al-Shahi Salman, R, T M Brock, M S Dennis, P A G Sandercock, P M Whites and C Warlow 2007. Research governance impediments to clinical trials: a retrospective survey. Journal of the Royal Society of Medicine, 100, 101-104.
2. Andersen, L, M Gwaltney, D Sundra, R Brownson, M Kane, A Cross, R Mack, R Schwartz, T Sims and C White 2006. Using concept mapping to develop a logic model for the Prevention Research Centers Program. Preventing Chronic Disease, 3(1).
3. Bain, L J 2005. Crossroads in clinical trials. Journal of the American Society for Experimental NeuroTherapeutics, 2, 525-528.
4. Balas, E A and S A Boren 2000. Managing clinical knowledge for health care improvement. Yearbook of Medical Informatics, 65-69.
5. Berndt, E R, A H B Gottschalk, T J Philipson and M B Strobeck 2005. Industry funding of the FDA: effects of PDUFA on approval times and withdrawal rates. Nature Reviews: Drug Discovery, 4, 545-554.
6. Burman, W J, R R Reves, D L Cohn and R T Schooley 2001. Breaking the camel's back: multicenter clinical trials and local institutional review boards. Annals of Internal Medicine, 134(2), 152-157.
7. Cheng, S, M Dietrich, S Finnigan, A Sandler, J Crites, L Ferranti, A Wu and D Dilts 2009. A sense of urgency: evaluating the link between clinical trial development time and the accrual performance of CTEP-sponsored studies. Journal of Clinical Oncology, 27(18s) (suppl; abstr CRA6509).
8. Cozzens, S E 1997. The knowledge pool: measurement challenges in evaluating fundamental research programs. Evaluation and Program Planning, 20, 77-89.
9. Dilts, D M and A B Sandler 2006. Invisible barriers to clinical trials: the impact of structural, infrastructural and procedural barriers to opening oncology clinical trials. Journal of Clinical Oncology, 24(28), 4545-4552.
10. Dilts, D M, A B Sandler, M Baker, S K Cheng, S L George, K S Karas, S McGuire, G S Menon, J Reusch, D Sawyer, M Scoggins, A Wu, K Zhou and R L Schilsky 2006. Processes to activate phase III clinical trials in a cooperative oncology group: the case of cancer and Leukemia Group B. Journal of Clinical Oncology, 24(28), 4553-4557.
11. Dilts, D M, A B Sandler, S Cheng, J Crites, L Ferranti, A Wu, R Gray, J MacDonald, D Marinucci and R Comis 2008. Development of clinical trials in a cooperative group setting: the Eastern Cooperative Oncology Group. Clinical Cancer Research, 14(11), 3427-3433.
12. Dilts, D M, A B Sandler, S K Cheng, J S Crites, L B Ferranti, A Y Wu, S Finnigan, S Friedman, M Mooney and J Abrams 2009. Steps and time to process clinical trials at the Cancer Therapy Evaluation Program. Journal of Clinical Oncology, 27(11), 1761-1766.
13. Edgerton, D E H 1999. Before big science: the pursuit of modern chemistry and physics, 1800-1940. Annals of Science, 56(1), 100-107.
14. Edquist, C and L Hommen 1999. Systems of innovation: theory and policy for the demand side. Technology in Society, 21, 63-79.
15. Emanuel, E J, A Wood, A Fleischman, A Bowen, K A Getz, C Grady, C Levine, D E Hammerschmidt, R Faden, L Eckenwiler, C T Muse and J Sugarman 2004. Oversight of human participants research: identifying problems to evaluate reform proposals. Annals of Internal Medicine, 141(4), 282-291.
16. Gunsalus, C K, E M Bruner, N C Burbules, L Dash, M Finkin, J P Goldberg, W T Greenough, G A Miller and M G Pratt 2006. Mission creep in the IRB world. Science, 312(5779), 1441.
17. Havey, M 2005, Essential Business Process Modeling. Sebastopol, CA: O'Reilly Media.
18. Jordan, G B, J Hage and J Mote 2008. A theories-based systemic framework for evaluating diverse portfolios of scientific work, part 1: micro and meso indicators. New Directions for Evaluation, 118, 7-24.
19. Kagan, J M, M Kane, K M Quinlan, S Rosas and W M K Trochim 2009. Developing a conceptual framework for an evaluation system for the NIAID HIV/AIDS clinical trials networks. Health Research Policy and Systems, 7(12).
20. Kagan, J M, N Gupta, S Varghese and H Virkar 2010. The NIAID Division of AIDS Enterprise Information System: a web-based clinical trials portfolio management system. Submitted.
21. Kane, M and W M Trochim 2007. Concept Mapping for Planning and Evaluation. Thousand Oaks, CA: Sage Publications.
22. Larédo, Philippe 2001. Benchmarking of RTD policies in Europe: 'research collectives' as an entry point for renewed comparative analysis. Science and Public Policy, 28(4), August, 285-294.
23. Nass, S J and B W Stillman 2003. Large-Scale Biomedical Science: Exploring Strategies for Future Research. Washington, DC: National Academies Press.
24. Pardo, T A, S S Dawes, A M Cresswell, F Thompson and G Kumar Tayi 2002. Finding Our Future: a Research Agenda for the Research Enterprise. Albany, NY: Center for Technology in Government, University at Albany, SUNY.
25. Patton, M Q 2008. Utilization Focused Evaluation, 4th edn. Thousand Oaks, CA: Sage Publications.
26. Quinlan, K M, M Kane and W M Trochim 2008. Evaluation of large research initiatives: outcomes, challenges and methodological considerations. New Directions for Evaluation, 118, 61-72.
27. Schedlbauer, M 2010. The Art of Business Process Modeling: the Business Analyst's Guide to Process Modeling with UML & BPMN. Sudbury, MA: The Cathris Group.
28. Stokols, D, J Fuqua, J Gress, R Harvey, K Phillips, L Baezconde- Garbanati, J Unger, P Palmer, M Clark, S Colby, G Morgan and W Trochim 2003. Evaluating transdisciplinary science. Nicotine and Tobacco Research, 5(S-1), S21-S39.
29. Trochim, W 2010. Translation Won't Happen Without Dissemination and Implementation: Some Measurement and Evaluation Issues. Keynote address at the 3rd Annual NIH Conference on the Science of Dissemination and Implementation, Bethesda, MD, 16 March 2010.
30. Trochim, W M 1989. An introduction to concept mapping for planning and evaluation. Evaluation and Program Planning, 12(1), 1-16.
31. Trochim, W M, S E Markus, L C Masse, R P Moser and P C Weld 2008. The evaluation of large research initiatives: a participatory integrative mixed-methods approach. American Journal of Evaluation, 29(1), 8-28.
32. UNAIDS 2007. AIDS epidemic update. December. .
33. Van der Meulen, Barend, and Arie Rip 2000. Evaluation of societal quality of public sector research in the Netherlands. Research Evaluation, 8(1), April, 11-25.